Celia R.
- Country
- Portugal
- Department
- Rheumatology
Research Overview
- Evaluation of Cenerimod Efficacy and Safety in Adults with Moderate-to-Severe Systemic Lupus Erythematosus: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of Long-Term Safety and Tolerability of Cenerimod in Adults with Moderate-to-Severe Systemic Lupus Erythematosus on Background Therapy
Data & Insights
Has run more than one trial at 19 of 54 partner sites.
Specializations
Autoimmune Disorders
The investigator specializes in the treatment and research of systemic lupus erythematosus (SLE), with particular focus on moderate to severe manifestations of the condition.
- Disease Activity Management
- Long-term Treatment Approaches
- Background Therapy Integration
Their research encompasses therapeutic interventions for autoimmune conditions, with emphasis on novel treatment modalities for lupus management.
Clinical Assessment
The investigator focuses on evaluating safety and tolerability profiles of innovative therapies for autoimmune conditions, particularly in adult populations with SLE.
- Treatment Effectiveness Analysis
- Safety Monitoring
- Therapeutic Response Assessment
Their work involves comprehensive evaluation of treatment outcomes in chronic autoimmune conditions.
Therapeutic Innovation
The investigator explores advanced therapeutic options for managing systemic autoimmune disorders, focusing on integrating new treatments with existing therapeutic regimens.
- Treatment Development
- Therapeutic Optimization
- Clinical Response Evaluation
Their research involves assessing innovative therapeutic approaches for autoimmune disease management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.